Bone 68 (2014) 166
Contents lists available at ScienceDirect
Bone journal homepage: www.elsevier.com/locate/bone
Letter to the Editor Regarding screening for atypical femur fractures I greatly appreciate the comments of Drs Yueju and Yingze. It is clear that atypical femur fractures are rather rare outcomes. A very large sample size would indeed be required to attempt to screen for true atypical femur fractures. What is not known, however, is the incidence of pre-fracture lesions. Our study simply shows that, even in a high risk group of patients who have taken bisphosphonates for five years or more, radiographic precursors of atypical femur fracture were
http://dx.doi.org/10.1016/j.bone.2014.06.025 8756-3282/© 2014 Elsevier Inc. All rights reserved.
not observed. While MRI or bone scan would be more sensitive, the cost of these imaging studies precludes their widespread use as a screening tool.
Timothy Bhattacharyya E-mail address: [email protected]. 17 June 2014
Contents lists available at ScienceDirect
Bone journal homepage: www.elsevier.com/locate/bone
Letter to the Editor Regarding screening for atypical femur fractures I greatly appreciate the comments of Drs Yueju and Yingze. It is clear that atypical femur fractures are rather rare outcomes. A very large sample size would indeed be required to attempt to screen for true atypical femur fractures. What is not known, however, is the incidence of pre-fracture lesions. Our study simply shows that, even in a high risk group of patients who have taken bisphosphonates for five years or more, radiographic precursors of atypical femur fracture were
http://dx.doi.org/10.1016/j.bone.2014.06.025 8756-3282/© 2014 Elsevier Inc. All rights reserved.
not observed. While MRI or bone scan would be more sensitive, the cost of these imaging studies precludes their widespread use as a screening tool.
Timothy Bhattacharyya E-mail address: [email protected]. 17 June 2014
